Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors

Current Management of Intracranial Germ Cell Tumours

(2018) A. Bowzyk Al-Naeeb et al.   CLINICAL ONCOLOGY

Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors

(2018) Mohammad H. Abu Arja et al.   CHILDS NERVOUS SYSTEM

Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy

(2017) Matthew J. Murray et al.   INTERNATIONAL JOURNAL OF CANCER

Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial

(2017) Gabriele Calaminus et al.   NEURO-ONCOLOGY

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group

(2016) Christoph Seidel et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study

(2015) Stewart Goldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study

(2013) Hee Jo Baek et al.   JOURNAL OF NEURO-ONCOLOGY

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

(2011) Karin Oechsle et al.   EUROPEAN UROLOGY